This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Biosimilars
Biosimilars
Risk management of biosimilars in the EU
EU takes the lead in shaping the future of biosimilars
Approval of biosimilar medicines
Biosimilar shows “no additional safety concerns”
Indian biosimilar one step closer to EU market
Biosimilars panel at BIO-Europe Spring conference
A current perspective on biopharmaceuticals
Cutting-edge issues on the agenda at ASHP midyear meeting
EMEA gives positive opinion to Teva biosimilar
French firm sets up potent-molecule plant
The future of biosimilars
Study backs biosimilar Valtropin’s safety
« Previous
1
…
5
6
7
8
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: